BIOA - BioAge Labs Profit before interest, taxes and amortization

Brandmark of BioAge (BIOA)

BioAge Labs, Inc. (BIOA) is a longevity innovator whose analytical platform is attracting the attention of scientists. Actual EBITDA reflects cash flow dynamics, while the 0.00 metric determines the status of the profit parameter. Growth is constrained by supply chain disruption risks and complexities regarding foreign patenting. The environmental footprint remains minimal due to compliance with basic laboratory regulations.

BioAge Labs Inc. - BIOA Operating profit EBITDA (period 11/23/2025 - 11/11/2026)

Summary analytical data breakdowns for BioAge (BIOA)

- current quotes and average value forecast:
Stock Quotes BioAge Labs, Inc|BIOA - Analyst Consensus Forecast
- market capitalization statistics:
Market Value BioAge Labs, Inc.|BIOA - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share BioAge Labs, Inc.|BIOA - Book Capitalization|Market Capitalization to Book Value Ratio bioagelabs.com|BIOA - Company Total Assets
- company total debt and liquidity indicators:
Debt to Equity BioAge Labs, Inc.|BIOA - Long-Term Debt to Equity|Current Liabilities to Capital BioAge Labs|BIOA - Company Debts|Debt to Book Capitalization Ratio BioAge Labs, Inc.|BIOA - Company Long-Term Debts|Short-Term Debt Volume BioAge Labs, Inc.|Interim Coverage Ratio bioagelabs.com
- financial results and valuation multiples details:
BIOA - Company Net Income|Future Profit BioAge Labs, Inc.|BIOA - P/E Multiple|Future Price to Earnings bioagelabs.com|BIOA - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio BioAge Labs, Inc.|BIOA - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months BioAge Labs, Inc.|BIOA - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth bioagelabs.com|BIOA - Earnings growth in current year|Net earnings per one share growth forecast for next year BioAge Labs, Inc.
Analysis of all company metrics:BioAge Labs, Inc (BIOA)
Manufactured products of BioAge Labs, Inc.

This indicator captures the daily cash balance of operating profit, reflecting the real balance of market supply and demand excluding depreciation and taxes. Analyzing the absolute EBITDA level for BioAge Labs, Inc. (BIOA) allows for an assessment of R&D stage efficiency within the anti-obesity drug segment, although sharp volatility in the metric during a trend reversal signals high entry risks prior to a potential asset drawdown.

Who BioAge Labs, Inc. competes with

ASND - Operating profit before deduction of amortization|Madrigal Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Operating profit before deduction of amortization|AKRO: Company profit before taxes, interest and amortization|MTSR (Metsera Corp) - Operating profit EBITDA|Operating profit EBITDA MoonLake Corp|Operating profit EBITDA CRNX|Profit before payment of interest, taxes and amortization NAMS (newamsterdampharma.com)|Profit before payment of interest, taxes and amortization Soleno Therapeutics, Inc. SLNO|Amicus Therapeutics Inc (FOLD) - Profit before interest, taxes and amortization|ETNB - Profit before payment of interest, taxes and amortization|AGIO: Profit before payment of interest, taxes and amortization|GPCR: Operating profit EBITDA|MDXG - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rezolute|Lexicon Pharmaceuticals Inc (LXRX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization MBX Bio (MBX)|Operating profit before deduction of amortization Altimmune Pharma ALT|Operating profit EBITDA AARD (Aardvark Therapeutics Inc)|sagimet.com - Profit before payment of interest, taxes and amortization|Biomea Fusion - Operating profit EBITDA|Operating income before deduction of amortization Quince Therapeutics QNCX|Fractyl (GUTS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization vTv Therapeutics (VTVT)|ATPC (Agape ATP Corp) - Operating profit EBITDA|Operating profit EBITDA Pluri Inc|Operating profit EBITDA SYBX|Lipocine Inc (LPCN) - Operating profit before depreciation charges|Operating profit EBITDA MTNB (Matinas BioPharma Holdings)|sprucebiosciences.com (SPRB) - Profit before interest, taxes and amortization|GLTO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization CTCX (carmellrx.com)|Lumos Pharma (LUMO) - Profit before payment of interest, taxes and amortization|ONVO (Organovo Holdings) - Profit before payment of interest, taxes and amortization|RDUS (Radius Health) - Operating profit EBITDA